Classical psychedelics for the treatment of depression and anxiety: A systematic review

Cited by (256)

Items 101–200 of 256

1. Focusing on the negative: cases of long-term negative psychological responses to psychedelics
   Rebecka Bremler, Nancy Katati, Parvinder Shergill, David Erritzøe, Robin Lester Carhart-Harris · 2023
2. Modulation of serotonin transporter expression by escitalopram under inflammation
   Sergio Mena, Allison Cruikshank, Janet A. Best, H. Frederik Nijhout, Michael C. Reed, Parastoo Hashemi · 2024 · Communications Biology
3. 5-hydroxytryptamine 2C/1A receptors modulate the biphasic dose response of the head twitch response and locomotor activity induced by DOM in mice
   Huili Zhu, Longyu Wang, Xiaoxuan Wang, Yishan Yao, Peilan Zhou, Ruibin Su · 2024 · Psychopharmacology
4. Neural Plasticity in the Ventral Tegmental Area, Aversive Motivation during Drug Withdrawal and Hallucinogenic Therapy
   Héctor Vargas-Pérez, Taryn Elizabeth Grieder, Derek van der Kooy · 2022 · Journal of Psychoactive Drugs
5. Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study
   Saral R. Desai, Vidisha Jain, Sona Xavier, Wei Du · 2022 · Children
6. Community-based psychedelic integration and social efficacy: An ethnographic study in the Southeastern United States
   Lisa L. Gezon · 2024 · Journal of Psychedelic Studies
7. The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models
   Amanda Argot Efthimiou, Amanda M. Cardinale, Agnieszka Kepa · 2024 · Psychedelic Medicine
8. Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
   Jack Stroud, Charlotte Rice, A Orsini, Marco Schlosser, Justine Lee, William Mandy, Sunjeev K. Kamboj · 2024 · Psychopharmacology
9. The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.
   Waguih William IsHak, Paloma García, Rachel Pearl, Jonathan Dang, Catherine William, Jayant Totlani, Itai Danovitch · 2023 · PubMed Central
10. Peyote as Earth Medicine: Examining How Symbolic Meanings Shape Experiences With Psychedelics
    Heith Copes, Jared Ragland · 2023 · The British Journal of Criminology
11. Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
    Marianne Destoop, Pavel Mohr, Florence Butlen‐Ducuing, Péter Kéri, Jerzy Samochowiec, Livia De Picker, Andrea Fiorillo, Kim P. C. Kuypers, Geert Dom · 2025 · European Psychiatry
12. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice
    Cindy A. Stein, Andrew Penn, Stephanie Hope, Caroline G. Dorsen, Mariavittoria Mangini · 2022 · Journal of Midwifery & Women s Health
13. Assessment of Psychological and Social Fitness in Healthy Adults Permanently Living at Very High Altitude
    Chun Gao, Jizong Ciren, Dan Wang, Zhaohui Zhang, Ruidong Ge, Li-e Yan · 2023 · International Journal of Environmental Research and Public Health
14. Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence
    Shannon Dames, Crosbie Watler, Pamela Kryskow, Pearl Allard, Michelle Gagnon, Wes Taylor, Vivian W. L. Tsang · 2024 · Psychedelic Medicine
15. Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation
    Daniel J. Kruger, Eirini K. Argyri, Justin K. Mogilski, Moss Herberholz, Julie Barron, Jacob S. Aday, Kevin F. Boehnke · 2025 · The Journal of Sex Research
16. Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India
    Ramesh Joga, Sravani Yerram, Jayasri Devi Patnam, Khushbhoo K Choudhary, Priya Changdev Varpe, Rajeev Singh Raghuvanshi, Saurabh Srivastava · 2025 · Health Policy
17. Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology
    Lucas M Wittenkeller, Gary A. Gudelsky, Theresa M. Winhusen, Davide Amato · 2025 · British Journal of Pharmacology
18. Perspective: Can psychedelic-assisted therapy be a promising aid in compulsive sexual behavior disorder treatment?
    Magdalena Wizła, Shane Winfield Kraus, Karol Lewczuk · 2022 · Comprehensive Psychiatry
19. Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review
    Tayler Holborn, Robert Lee Page II, Fabrizio Schifano, Paolo Deluca · 2023 · International Journal of Mental Health and Addiction
20. Psychedelics and substance use disorder treatment
    Caitlin M. DuPont, Matthew W. Johnson · 2025 · International review of neurobiology
21. Therapeutic Use of Hallucinogens
    Victor Distefano Wiltenburg, Dianne da Rocha Prado, F. Mendes · 2021 · Springer eBooks
22. Commodified Spirituality: Tourism and Indigenous Heritage Practices in Huautla De Jimenez, Mexico
    Diego Hannon Ovies, Juan Jorge Rodríguez Bautista · 2021 · Tourism Culture & Communication
23. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
    Teresa Reynolds de Sousa, João Rema, Sergio Eduardo de Carvalho Machado, Filipa Novais · 2021 · Current Topics in Medicinal Chemistry
24. Cosmology of belonging: The role of community in the therapeutic use of psychedelics
    Caroline G. Dorsen, Lola Noero, Michelle Knapp, Kristin Arden, William E. Rosa · 2025 · Palliative & Supportive Care
25. Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress
    Sean M. Viña · 2025 · Psychedelic Medicine
26. Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder
    Rebecca C. Ehrenkranz, Manish Agrawal, Jennifer Kim Penberthy, David B. Yaden · 2024 · International Review of Psychiatry
27. Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses
    Joe Hardy, Hannes Kettner, Justin Wall, Justin Wall, Robin Lester Carhart-Harris, Joseph L. Hardy · 2025 · Frontiers in Virtual Reality
28. Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges
    Sharmin Ghaznavi, Sarah G. Richter · 2025 · Drugs
29. New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances
    Matthias Forstmann, Christina Sagioglou · 2021 · European Psychologist
30. Treatment resistant depression
    Sophie R. Vaccarino, Sidney H. Kennedy · 2020 · Elsevier eBooks
31. Electrophysiological mechanisms of psychedelic drugs: A systematic review
    Javier Hidalgo Jiménez, Kristjan Kaup, Jaan Aru · 2026 · Neuroscience & Biobehavioral Reviews
32. Effects of Acute Drug Administration on Emotion: a Review of Pharmacological MRI Studies
    Kathryne Van Hedger, Leah M. Mayo, Anya K. Bershad, Racheal Madray, Harriet de Wit · 2021 · Current Addiction Reports
33. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
    Rabeet Tariq · 2022 · Current Clinical Pharmacology
34. Chronic Vestibular System Dysfunction After mTBI: Neuropsychology, Neuropsychiatry, Neuroscience and Treatment
    Amir A. Sepehry, I. Z. Schultz, Arthur I. Mallinson, Neil S. Longridge · 2024 · Psychological Injury and Law
35. The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress
    Sean M. Viña · 2025 · Healthcare
36. From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
    Aleksandra Kupferberg, Gregor Hasler · 2024 · Frontiers in Psychiatry
37. Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand
    Ethan Mills, Jai Whelan, Sarah McGruddy, Ryan D. Ward · 2025 · Journal of Psychoactive Drugs
38. Systematic characterization of Lysergic Acid Diethylamide metabolites in Caenorhabditis elegans by ultra-high performance liquid chromatography coupled with high-resolution tandem mass spectrometry
    Christiane Martins de Vasconcellos Silveira, Vanessa Farelo dos Santos, Isis Moraes Ornelas, Beatriz de Sá Carrilho, Matheus Antonio V. de C. Ventura, Henrique Marcelo Gualberto Pereira, Stevens Kastrup Rehen, Magno Junqueira · 2023 · Journal of Chromatography A
39. Stutterers’ experiences on classic psychedelics: A preliminary self-report study
    Eric S. Jackson, Noam Goldway, Hope Gerlach-Houck, Noah D. Gold · 2024 · Journal of Fluency Disorders
40. Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI
    Randall J. Olson, Lowell Bartlett, Alex Sonneborn, Russell Milton, Zachary Bretton-Granatoor, Ayesha Firdous, Alexander Z. Harris, Atheir I. Abbas · 2023 · Neuropharmacology
41. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
    Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople et al. · 2024 · Trials
42. MDMA – hopes and fears associated with therapeutic use in mental disorders
    Kamil Kozera, Lena Cichoń, Krzysztof Maria Wilczyński, Małgorzata Honorata Janas-Kozik · 2020 · Pharmacotherapy in Psychiatry and Neurology
43. Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis
    Christoffer Dharma, Esther Liu, Daniel Grace, Carmen H. Logie, Alex Abramovich, Nicholas Mitsakakis, Neill Bruce Baskerville, Michael Chaiton · 2024 · Journal of Epidemiology & Community Health
44. Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
    Maximiliano Zeller · 2024 · Philosophical Psychology
45. Pharmacological management of depressive disorders
    Anthony James Cleare, Roman Dunčko, Vidya Giri Shankar · 2024 · Medicine
46. Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians
    Sean M. Viña · 2025 · Psychoactives
47. Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine
    Charles Dodds, Rachelle L. Dawson, Alexander Lim, Susannah J. Tye, Fatima Ali Nasrallah · 2025 · Therapeutic Advances in Psychopharmacology
48. Toward dimensional body consciousness impairments in post-traumatic stress disorder and its dissociative subtype: A predictive processing approach
    Andrew Laurin, Hugo Bottemanne, Samuel Bulteau, Mohamad El Haj, Anne Sauvaget, Thibault Deschamps · 2026 · Neuroscience & Biobehavioral Reviews
49. Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones
    Sean P. Goldy, Nathan D. Sepeda, Samantha N. Hilbert, Bilal A. Bari, Albert Garcia‐Romeu, Natalie Gukasyan, Frederick Streeter Barrett, David B. Yaden, Sandeep Manel Nayak · 2026 · Psychiatry Research
50. Psilocybin alters visual contextual computations
    Marco Aqil, Gilles de Hollander, Nina Vreugdenhil, Tomas H. J. Knapen, Serge Olaf Dumoulin · 2025 · Nature Communications
51. Antidepressants: A content analysis of healthcare providers' tweets
    Yijun Dong, Natalie Weir · 2023 · Exploratory Research in Clinical and Social Pharmacy
52. Changes in Social and Sex Behaviors in Rats in Response to Stress and Restoration by Negative Allosteric Modulators of Gaba Receptors
    Aileen M. Bailey, Allison Barrett, Lane Havens, Erica C. Leyder, Taylor Merchant, Hannah M. Starnes, Scott M. Thompson · 2023 · Behavioural Brain Research
53. A bibliometric analysis of research on psychedelics for depression treatment
    Hao Hua, Xinghuo Fu, Wenli Wang, Sen Wang, Di Wang, Zifeng Wu, Qi Zhang, Teng He, Chun Yang · 2024 · Heliyon
54. Psilocybin: A brief overview for psychiatric mental health nurse practitioners
    Dina Fradkin · 2021 · Perspectives In Psychiatric Care
55. Editorial
    Christina Marel, Katherine L. Mills, Robert Stirling, Jack Wilson, Paul Haber, Maree Teesson · 2021 · Advances in Dual Diagnosis
56. Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome
    Erin E. Mauney, Franklin King, Helen Burton Murray, Braden Kuo · 2025 · Journal of Clinical Gastroenterology
57. Nature’s Mental Health Toolkit: Herbal Remedies for Anxiety and Depression
    Anshika Garg · 2025 · Research Journal of Pharmacognosy and Phytochemistry
58. Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N -dimethyltryptamine and harmine in a meditation retreat
    Klemens Egger, Daniel Meling, Feyza Polat, Erich Seifritz, Mihai Avram, Milan Scheidegger · 2025 · Imaging Neuroscience
59. With great power comes great responsibility: Promise and caution in the new psychedelic renaissance
    Matthew T. J. Halma, Rakeem Levy, Joseph Varón · 2025 · Brain Disorders
60. The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis
    Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravani-Nezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar · 2026 · BMC Psychology
61. Nervous and Scared
    Phyllis R. Peterson, Rodney Ho · 2021 · Physician Assistant Clinics
62. Considerations in the Application of Psychedelic-Augmented Psychotherapy: A Commentary on Clinical Mechanisms
    Alexander De Foe · 2023 · Psychoactives
63. Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory
    Héctor Vargas-Pérez, Fernando Minauro‐Sanmiguel, Ryan A. Ting‐A‐Kee, Taryn Elizabeth Grieder, Mónica Méndez‐Díaz, Oscar E. Prospero-Garcia, Derek van der Kooy · 2023 · Neuroscience Letters
64. NPS pharmacology and toxicology
    Roy R. L. Gerona · 2024 · Elsevier eBooks
65. The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis
    Jia-Ru Li, Kuo-Tung Chiang, Yu‐Chen Kao, Chia‐Ling Yu, Fu‐Chi Yang, Chih‐Sung Liang, Tien‐Wei Hsu · 2024 · Journal of Affective Disorders
66. Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need
    Daan de Jonge, Pim B. van der Meer, Cornelis Kramers, Arnt Schellekens · 2024 · Current Psychiatry Reports
67. Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
    Nadine Loh, David P. Luke · 2025 · Psychoactives
68. An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action
    Maria Emanuelle Damazio Lima, Isian Santos da Silva, Mariana de Oliveira Leal Desmarais, Thais Cardoso de Oliveira, Davyson de Lima Moreira, Alessandra Leda Valverde · 2021 · Revista Virtual de Química
69. A Semantic Scale Network analysis of the revised Mystical Experiences Questionnaire: A call for collaboration
    Mitch Earleywine, Fiona Low, Joseph Anthony De Leo · 2021 · Journal of Psychedelic Studies
70. Anxiety and personality
    Neil McNaughton, J.A. Gray · 2024 · Oxford University Press eBooks
71. The top ten things that must be known about end of life therapy in patients with advanced cancer
    Gudrun Kreye, Bettina Heidecker, Eva Katharina Masel · 2020 · memo - Magazine of European Medical Oncology
72. Propriété égolytique des psychédéliques et intérêts dans le traitement de la dépression
    Baptiste Fauvel, Justine Mutlu, Pascale Piolino · 2020 · Psychologie Française
73. The Basis For A Neurobiological-Associative Model of Personality and Group Cohesion: The Evolutionary And System Biological Origins Of Social Exclusion, Hierarchy, and Structure
    Michael E. Thomas · 2020 · Preprints.org
74. Psychedelic Therapy: Beyond Brain, Embracing Culture
    Inês Hipólito, Sofia Tzima · 2023
75. Comparison of the effectiveness of treatments based on compassion, acceptance and commitment, and mindfulness on anxiety disorders and depression: A systematic review and meta-analysis
    Salari, Nader, Heidarian, Pegah, Hassani, Roya, Babajani, Fateme, Abdolmaleki, Amir, Mohammadi, Masoud · 2024 · Journal of Affective Disorders Reports
76. Articulation de la thérapie d’acceptation et d’engagement à la psychothérapie assistée par psychédéliques en addictologie
    Lana Strika-Bruneau, Baptiste Fauvel, David Dupuis, Amine Benyamina · 2023 · L Évolution Psychiatrique
77. The psychedelic experience: a new perspective, a new attitude towards the world
    Virginia Ballesteros · 2024 · Oxford University Press eBooks
78. A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life
    Sarah Kratina, Carol Strıke, Robert D. Schwartz, Ayah Nayfeh, Sydney A. Jopling, Christopher Lo, Brian R. Rush · 2025 · PLoS ONE
79. Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation
    Nicholas P. Cherup, Patrick H. Finan · 2025 · Journal of Pain
80. Exploring the effects of microdosing on health behaviour change
    Luisa Prochazkova, Laura Lopes de Carvalho, Natasza Marrouch, Jorge Encantado, Pedro J. Teixeira · 2025 · Neuropharmacology
81. Ceremonial Psychedelic Experiences and Changes in Mental Health Outcomes in Those with Adverse Childhood Experiences
    Maryam Mehmood, Rebecka Bremler, Meg J. Spriggs, Hannes Kettner, Leor Roseman, Lasse Damgaard, Robin Lester Carhart-Harris, David Erritzøe, Richard J. Zeifman · 2025 · Psychedelic Medicine
82. Associations of Couples’ Psychedelic Use with Shared Reality and Relational Well-Being
    Talea M. Cornelius, Tommaso Barba · 2026 · Journal of Psychoactive Drugs
83. Unequal Healing: Gender, Psychedelics, and the Burden of Care
    Sean M. Viña · 2026 · Women & Therapy
84. The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study
    Gláucio Silva Camargos, Geraldo Magela de Faria, Marcelo Lourenço, Gerardo Maria de Araújo Filho · 2026 · Frontiers in Psychiatry
85. Preliminary effects of ayahuasca on mental and physical health: A systematic review of prospective studies
    Michael J. Haupt, Savannah Carra, Kevin F. Boehnke, Jacob S. Aday · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
86. Intention-Setting Among Recreational Psychedelic Users: Associated Acute Effects and Changes in Well-Being
    Fiona Low, Mitch Earleywine · 2026 · Journal of Psychoactive Drugs
87. Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review
    Maria Laura Mele, Stefano Federici · 2026 · Frontiers in Psychiatry
88. Perioperative considerations for patients exposed to hallucinogens
    Trent D. Emerick, Tetyana Marshall, Thomas Jeff Martin, Doug Ririe · 2024 · Regional Anesthesia & Pain Medicine
89. Fundamentals of the septo-hippocampal system
    Neil McNaughton, J.A. Gray · 2024 · Oxford University Press eBooks
90. Memory and the septo-hippocampal system
    Neil McNaughton, J.A. Gray · 2024 · Oxford University Press eBooks
91. The 7th Annual Psyche Awards: Honoring the Most Valuable Papers in Mental Health Care
    James C. Overholser · 2024 · Journal of Contemporary Psychotherapy
92. Identification and management of anxious depression in patients with treatment-resistant depression
    Rachel Hershenberg, Mark Hyman Rapaport, Kamile Weischedel · 2022 · Elsevier eBooks
93. Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review
    Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla · 2021 · Research Society and Development
94. La ciencia psicodélica del siglo XXI
    Nahuel Enrique Baca · 2023 · Vertex Revista Argentina de Psiquiatría
95. Ayahuasca no tratamento da farmacodependência à cocaína: possíveis intervenções terapêuticas?
    Vítor Bruno · 2019
96. Psilocybin-Assisted Psychotherapy: Treating Depression and Anxiety with Mushrooms
    Sofia Beck · 2020
97. Psychotherapeutic and neurobiological processes associated with ayahuasca’s mental health and wellbeing outcomes: a proposed model and implications for therapeutic use
    Daniel Perkins, Simon Ruffell, Kimberley Day, Diego Pinzon, Jerome J. Sarris · 2022
98. Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
    Daisy Lutyens · 2023 · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare)
99. The classic psychedelic DOI induces a persistent desynchronized state in medial prefrontal cortex
    Randall J. Olson, Lowell Bartlett, Alex Sonneborn, Zachary Bretton-Granatoor, Ayesha Firdous, Alexander Z. Harris, Atheir I. Abbas · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
100. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression
     Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople et al. · 2023 · Research Square